Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (720)	6/16/1999 11:47:00 PM
From: LLCF	Read Replies (1) of 4974

< Lot easier to justify acquisition using overvalued paper. Not sure, but for now I think the fall in the prices of drug stocks is a slight negative> You know what... I know the above would be conventional wisdom, but I don't buy it. First of all, once bio buyouts become in vogue... the slight problem of weak or strong currency won't matter, they'll just do it, they'll have to in order to keep up with the Joneses. Once the seed is planted they'll all just do it. Second think of past merger waves in ANY industry, things so much crazier than todays prices in bioworld have happened in each one, it makes todays bio prices look silly cheap. Lastly, look at the value of the deals we're talking about, the buyers stock price wouldn't effect them much unless a serious bear market started. IMO all the big pharma stocks could correct 50% and it wouldn't mean beans to bio buyouts. This has just started... get on board! DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next